Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Bevacizumab and micrometastases: Revisiting the preclinical and clinical rollercoaster — Giannis Mountzios (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Bevacizumab and micrometastases: Revisiting the preclinical and clinical rollercoaster
Shared by
Peter Carmeliet
Aarhus University
Bevacizumab and micrometastases: Revisiting the preclinical and clinical rollercoaster
Article
2013
en
Authors
GM
Giannis Mountzios
GP
George Pentheroudakis
Peter Carmeliet
Aarhus University
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2007
Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell
Richard A Scolyer
,
Rajmohan Murali
,
Jeffrey E. Gershenwald
,
Alistair J. Cochran
,
John F. Thompson
Article
2008
The detection and significance of melanoma micrometastases in sentinel nodes
Richard A Scolyer
,
Rajmohan Murali
,
Imke Satzger
,
John F. Thompson
Article
2024
Relaxin agonists under preclinical and early clinical investigation for the treatment of heart failure
Ashwin Ajay
,
Hanan Ajay
,
Rajiv Tripathi
,
Gregory Y H Lip
,
Rajiv Sankaranarayanan
Article
2005
Emerging applications of kinetic biomarkers in preclinical and clinical drug development.
Scott Turner
,
Marc Hellerstein
Article
2011
Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications
Aspasia Soultati
,
Giannis Mountzios
,
Chrysoula Avgerinou
,
George Papaxoinis
,
Dimitrios Pectasides
,
Meletios A Dimopoulos
,
Christos Papadimitriou
Discussion(0)
No comments yet. Be the first to comment.